Entity
  • GENOSKIN

    Created in 2011
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    336 6,779
  • Activities

  • Technologies

  • Entity types

  • Location

    4 Technology Way, Salem, MA 01970, USA

    Salem

    United States of America

  • Employees

    Scale: 11-50

    Estimated: 44

  • SIREN

    535121933
  • Engaged corporates

    18
    6 10
  • Added in Motherbase

    5 years, 8 months ago
Description
  • Value proposition

    Redefining Non-Clinical Research with Live Human Skin

    Genoskin brings unparalleled expertise in skin biology and immunology to advance your research and drug development efforts. Our mission is to provide reliable human data before regulatory studies for human therapeutics, vaccines, medical devices, cosmetics, and chemicals. Using natural human skin obtained through donations, we keep the skin alive for up to seven days post-surgery with a proprietary patented technology—enabling a full week of testing across all cell types and skin structures. Unlike animal or engineered models, our platforms offer authentic, human-relevant data. Supported by advanced assays, from imaging techniques to next-generation sequencing, and deep scientific insights, we deliver the data you need to confidently advance your projects with speed and precision.

    Skin explant, Vaccine development, Cosmetics testing , Mast cells , Contract research organization (CRO), Medical devices testing , Toxicity testing , Injection site reactions, Live human tissue, Preclinical drug development , Early-phase development, Beauty products testing, Human skin models, Ex vivo skin models , Transcriptomic analysis, Preclinical studies, Nonclinical testing , and Biologics testing

  • Ex vivo human skin models from donated human skin - Genoskin

    Genoskin's technology maintains ex vivo human skin models alive and functional for at least 7 days. Let's accelerate science together!

  • https://genoskin.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Illumina
Illumina
Biotechnology, Biotechnology Research
Illumina
Biotechnology, Biotechnology Research
Other

14 Nov 2023


Dassault Systèmes
Dassault Systèmes
IT services, Software Development
Dassault Systèmes
IT services, Software Development
Other

14 Nov 2023


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

26 Oct 2023


GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing
GSK
Pharmaceutical, Pharmaceutical Manufacturing
Other

26 Oct 2023


CNRS
CNRS
Research, Research Services
CNRS
Research, Research Services
Other

5 Mar 2023


Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration
Other

16 Nov 2023


France Digitale
France Digitale
Startup accelerator & VC, Non-profit Organizations
France Digitale
Startup accelerator & VC, Non-profit Organizations
Other

11 Nov 2022


Maison du doctorat - Université Paris-Saclay Maison du doctorat - Université Paris-Saclay
Research, Higher Education
Other

21 Jan 2021


Cosmetic Valley
Cosmetic Valley
Cosmetics, Public business cluster, French Cluster, Personal Care Product Manufacturing
Cosmetic Valley
Cosmetics, Public business cluster, French Cluster, Personal Care Product Manufacturing
Not capitalistic
Partnership
Event

9 Jul 2021


Eurobiomed
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Not capitalistic
Not partnership
Event

5 Jun 2019


Similar entities
Loading...
Loading...
Social network dynamics